Free Newsletter
Charmeil named Sanofi vaccines head
Sanofi-Aventis has named Olivier Charmeil as its new senior VP of vaccines. Charmeil previously covered the Asia-Pacific and Japan regions in the company's pharmaceutical division, which Sanofi CEO Christopher Viehbacher says is an asset to vaccines, as it focuses on emerging markets. The leadership change will occur Jan. 1, as Wayne Pisano steps down. Sanofi release | Article
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
More Research Reports >>
SHARE
WITH: